Arteris, Inc. (NASDAQ:AIP) Short Interest Down 12.9% in January

Arteris, Inc. (NASDAQ:AIP - Get Free Report) saw a significant decrease in short interest in the month of January. As of January 31st, there was short interest totalling 385,400 shares, a decrease of 12.9% from the January 15th total of 442,500 shares. Approximately 1.5% of the company's stock are short sold. Based on an average daily trading volume, of 265,500 shares, the short-interest ratio is presently 1.5 days.

Analyst Ratings Changes

AIP has been the subject of several recent research reports. Northland Securities increased their price objective on Arteris from $14.00 to $16.00 and gave the stock an "outperform" rating in a report on Wednesday. Rosenblatt Securities reiterated a "buy" rating and set a $15.00 price objective on shares of Arteris in a report on Tuesday. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $13.60.

Insider Transactions at Arteris

In other news, VP Paul L. Alpern sold 2,471 shares of the stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $11.41, for a total transaction of $28,194.11. Following the sale, the vice president now directly owns 64,930 shares in the company, valued at approximately $740,851.30. This represents a 3.67 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Nicholas B. Hawkins sold 5,000 shares of the firm's stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $8.56, for a total value of $42,800.00. Following the completion of the sale, the chief financial officer now owns 190,414 shares in the company, valued at approximately $1,629,943.84. This represents a 2.56 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 367,157 shares of company stock valued at $3,828,388 over the last quarter. Company insiders own 33.70% of the company's stock.

Institutional Trading of Arteris

Several institutional investors and hedge funds have recently made changes to their positions in AIP. Needham Investment Management LLC raised its position in shares of Arteris by 14.7% during the 3rd quarter. Needham Investment Management LLC now owns 2,735,000 shares of the company's stock valued at $21,114,000 after acquiring an additional 350,000 shares during the last quarter. G2 Investment Partners Management LLC bought a new stake in shares of Arteris during the 4th quarter valued at $2,799,000. Federated Hermes Inc. raised its position in shares of Arteris by 729.4% during the 4th quarter. Federated Hermes Inc. now owns 165,878 shares of the company's stock valued at $1,690,000 after acquiring an additional 145,878 shares during the last quarter. Arrowstreet Capital Limited Partnership bought a new stake in shares of Arteris during the 4th quarter valued at $1,272,000. Finally, EAM Investors LLC bought a new stake in shares of Arteris during the 4th quarter valued at $983,000. Institutional investors own 64.36% of the company's stock.

Arteris Stock Performance

AIP stock traded down $0.14 during trading on Thursday, reaching $9.85. 248,574 shares of the stock were exchanged, compared to its average volume of 325,311. Arteris has a twelve month low of $5.76 and a twelve month high of $12.64. The company has a market capitalization of $395.77 million, a P/E ratio of -11.32 and a beta of 1.18. The stock has a 50 day simple moving average of $10.55 and a 200-day simple moving average of $8.71. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30.

Arteris (NASDAQ:AIP - Get Free Report) last posted its earnings results on Tuesday, February 18th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.08). Arteris had a negative net margin of 58.27% and a negative return on equity of 578.17%. The firm had revenue of $15.49 million during the quarter, compared to the consensus estimate of $15.34 million. As a group, sell-side analysts anticipate that Arteris will post -0.71 earnings per share for the current year.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.